CWA
GILD icon

Cypress Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Cypress Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,500
Closed -$238K – 121
2017
Q1 		$238K Sell
3,500
-735
-17% -$51.7K 0.11% 174
2016
Q4 		$303K Buy
4,235
+261
+7% +$19.4K 0.14% 135
2016
Q3 		$314K Buy
3,974
+204
+5% +$16.6K 0.14% 133
2016
Q2 		$314K Sell
3,770
-105
-3% -$9.32K 0.16% 127
2016
Q1 		$356K Buy
3,875
+54
+1% +$4.87K 0.16% 118
2015
Q4 		$387K Buy
3,821
+92
+2% +$9.57K 0.2% 105
2015
Q3 		$366K Buy
3,729
+1,316
+55% +$146K 0.2% 109
2015
Q2 		$283K Buy
+2,413
New +$264K 0.17% 115

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cypress Wealth Advisors's GILD Position: Q2 2017 in Review

Cypress Wealth Advisors sold out of Gilead Sciences (GILD) in Q2 2017, closing a stake of 3,500 shares — an estimated $238K sold.

Cypress Wealth Advisors first reported a position in GILD in Q2 2015 and held it in 8 quarters. The position peaked at $387K in Q4 2015. 1,519 funds tracked by Wall St. Rank hold GILD as of Q2 2017.

  • Cypress Wealth Advisors reported no remaining Gilead Sciences position as of Q2 2017 after selling out during the quarter.
  • Cypress Wealth Advisors sold 3,500 Gilead Sciences shares in Q2 2017, an estimated $238K.
  • Cypress Wealth Advisors first reported a position in Gilead Sciences in Q2 2015 and held it in 8 quarters.
  • Cypress Wealth Advisors's Gilead Sciences position peaked at $387K in Q4 2015.
  • 1,519 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2017.

Based on Cypress Wealth Advisors's 13F filing for Q2 2017, filed 16 Aug 2017.